4//SEC Filing
LORD JONATHAN T MD 4
Accession 0001209191-21-040456
CIK 0000811240other
Filed
Jun 13, 8:00 PM ET
Accepted
Jun 14, 8:50 PM ET
Size
8.1 KB
Accession
0001209191-21-040456
Insider Transaction Report
Form 4
BIOLASE, INCBIOL
LORD JONATHAN T MD
Director
Transactions
- Award
Stock Appreciation Right
2021-06-11+189,902→ 189,902 totalExercise: $0.84Exp: 2031-06-11→ Common Stock (189,902 underlying) - Award
Restricted Stock Unit
2021-06-11+330,000→ 330,000 total→ Common Stock (330,000 underlying)
Footnotes (3)
- [F1]Of the stock appreciation rights subject to this SAR, one-fourth of the stock appreciation rights vest on each of the third, sixth, ninth, and twelfth-month anniversaries of the date of grant.
- [F2]At the option of the Company, each restricted stock unit represents the right to receive, at settlement, one share of common stock, or its cash equivalent.
- [F3]The restricted stock unit award fully vests and is immediately exercisable upon the filing with the SEC of the Annual Report on Form 10-K for the year ending December 31, 2023.
Documents
Issuer
BIOLASE, INC
CIK 0000811240
Entity typeother
Related Parties
1- filerCIK 0001112980
Filing Metadata
- Form type
- 4
- Filed
- Jun 13, 8:00 PM ET
- Accepted
- Jun 14, 8:50 PM ET
- Size
- 8.1 KB